SCOPE: Metabolic phenotyping promises to be a useful tool in human intervention studies. This study examined whether metabolic phenotyping could identify responders to vitamin D supplementation in terms of the metabolic syndrome. METHODS AND RESULTS: In a double-blind, randomised placebo-controlled dietary intervention subjects were assigned to receive 15 μg vitamin D(3) or placebo daily. Serum 25-hydroxyvitamin D (25(OH)D) and biochemical markers of the metabolic syndrome were measured at baseline and following the 4-wk intervention. k-means clustering and (1) H-NMR metabolomic analysis were used to explore responsive phenotypes. Vitamin D supplementation significantly increased serum 25(OH)D to an endpoint concentration of 78.1 ± 20.0 nmol/L (p<0.001). There was no effect of supplementation on the measured markers of the metabolic syndrome. k-means cluster analysis based on 13 biochemical markers of the metabolic syndrome and 25(OH)D concentrations revealed five discrete biomarker clusters. One of these clusters, characterised by lower serum 25(OH)D and higher levels of adipokines, showed significant responses in insulin (15% decrease), homestatic model assessment scores (19% decrease) and c-reactive protein (54% decrease). Metabolomic analysis revealed further changes and the extent of change in serum vitamin D correlated negatively with changes in glucose. CONCLUSION: Overall, metabolic phenotyping revealed a phenotype that was responsive to vitamin D supplementation.
RCT Entities:
SCOPE: Metabolic phenotyping promises to be a useful tool in human intervention studies. This study examined whether metabolic phenotyping could identify responders to vitamin D supplementation in terms of the metabolic syndrome. METHODS AND RESULTS: In a double-blind, randomised placebo-controlled dietary intervention subjects were assigned to receive 15 μg vitamin D(3) or placebo daily. Serum 25-hydroxyvitamin D (25(OH)D) and biochemical markers of the metabolic syndrome were measured at baseline and following the 4-wk intervention. k-means clustering and (1) H-NMR metabolomic analysis were used to explore responsive phenotypes. Vitamin D supplementation significantly increased serum 25(OH)D to an endpoint concentration of 78.1 ± 20.0 nmol/L (p<0.001). There was no effect of supplementation on the measured markers of the metabolic syndrome. k-means cluster analysis based on 13 biochemical markers of the metabolic syndrome and 25(OH)D concentrations revealed five discrete biomarker clusters. One of these clusters, characterised by lower serum 25(OH)D and higher levels of adipokines, showed significant responses in insulin (15% decrease), homestatic model assessment scores (19% decrease) and c-reactive protein (54% decrease). Metabolomic analysis revealed further changes and the extent of change in serum vitamin D correlated negatively with changes in glucose. CONCLUSION: Overall, metabolic phenotyping revealed a phenotype that was responsive to vitamin D supplementation.
Authors: Jessica A Alvarez; Elizabeth Y Chong; Douglas I Walker; Joshua D Chandler; Ellen S Michalski; Ruth E Grossmann; Karan Uppal; Shuzhao Li; Jennifer K Frediani; Rabindra Tirouvanziam; ViLinh T Tran; Vin Tangpricha; Dean P Jones; Thomas R Ziegler Journal: Metabolism Date: 2017-02-11 Impact factor: 8.694
Authors: Julia L Finkelstein; Eva K Pressman; Elizabeth M Cooper; Tera R Kent; Haim Y Bar; Kimberly O O'Brien Journal: Reprod Sci Date: 2014-11-02 Impact factor: 3.060
Authors: Magdalena Del Rocio Sevilla-Gonzalez; Alisa K Manning; Kenneth E Westerman; Carlos Alberto Aguilar-Salinas; Amy Deik; Clary B Clish Journal: BMJ Open Diabetes Res Care Date: 2022-10
Authors: Qian Gao; Giulia Praticò; Augustin Scalbert; Guy Vergères; Marjukka Kolehmainen; Claudine Manach; Lorraine Brennan; Lydia A Afman; David S Wishart; Cristina Andres-Lacueva; Mar Garcia-Aloy; Hans Verhagen; Edith J M Feskens; Lars O Dragsted Journal: Genes Nutr Date: 2017-12-12 Impact factor: 5.523
Authors: Susanne Vogt; Simone Wahl; Johannes Kettunen; Susanne Breitner; Gabi Kastenmüller; Christian Gieger; Karsten Suhre; Melanie Waldenberger; Jürgen Kratzsch; Markus Perola; Veikko Salomaa; Stefan Blankenberg; Tanja Zeller; Pasi Soininen; Antti J Kangas; Annette Peters; Harald Grallert; Mika Ala-Korpela; Barbara Thorand Journal: Int J Epidemiol Date: 2016-09-07 Impact factor: 7.196